SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-026293
Filing Date
2022-05-13
Accepted
2022-05-13 12:45:17
Documents
4
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea159602-def14a_pasitheathe.htm DEF 14A 365096
2 GRAPHIC image_001.jpg GRAPHIC 40385
3 GRAPHIC image_002.jpg GRAPHIC 764980
4 GRAPHIC image_003.jpg GRAPHIC 296852
  Complete submission text file 0001213900-22-026293.txt   1882467
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40804 | Film No.: 22921387
SIC: 2834 Pharmaceutical Preparations